Denali Therapeutics (DNLI)
Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement
Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025 Cannabis Holiday Gift Guide Highlights Canada’s Most Popular Cannabis Products for the Holiday Season
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the ASCO Gastrointestinal Cancers Symposium
Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress
Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results
BD and ChemoGLO™ Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories
Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors